Continuous IV infusion is the choice treatment route for argininevasopressin receptor blocker conivaptan in mice to study stroke-evoked Brain Edema

Journal of Visualized Experiments

Volumn 2016, Issue 115, 2016, Pages

  Zeynalov, Emil ^a   Jones, Susan M ^a   Elliott, J Paul ^b  

^a Swedish Medical Group   (United States)

^b Department of Neurosurgery   (United States)

Author keywords

Blood brain barrier; Brain edema; Brain infarct; Continuous IV infusion; Issue 115; Medicine; Middle cerebral artery occlusion; Mouse stroke model

Indexed keywords

BENZAZEPINE DERIVATIVE; CONIVAPTAN; VASOPRESSIN RECEPTOR; VASOPRESSIN RECEPTOR ANTAGONIST;

ANIMAL; BRAIN EDEMA; C57BL MOUSE; CEREBRAL ARTERY DISEASE; DISEASE MODEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; MOUSE; PATHOLOGY; RANDOMIZATION; STROKE;

ANIMALS; ANTIDIURETIC HORMONE RECEPTOR ANTAGONISTS; BENZAZEPINES; BRAIN EDEMA; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; INFUSIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION; RECEPTORS, VASOPRESSIN; STROKE;

EID: 84989328031     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/54170     Document Type: Article

References (22)

1. Gueniau, C., & Oberlander, C. The kappa opioid agonist niravoline decreases brain edema in the mouse middle cerebral artery occlusion model of stroke. J Pharmacol Exp Ther. 282, 1-6 (1997).
2. Krafft, P. R. et al. Etiology of stroke and choice of models. Int J Stroke. 7, 398-406 (2012).
3. Vakili, A., Kataoka, H., & Plesnila, N. Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia. J Cereb Blood Flow Metab. 25, 1012-1019 (2005).
4. Zeynalov, E., Jones, S. M., Seo, J. W., Snell, L. D., & Elliott, J. P. Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice. PloS one. 10, e0136121 (2015).
5. Med Lett Drugs Ther. Conivaptan (Vaprisol) for hyponatremia. The Medical letter on drugs and therapeutics. 48, 51-52 (2006).
6. Zhao, X. Y. et al. Effect of arginine vasopressin on the cortex edema in the ischemic stroke of Mongolian gerbils. Neuropeptides. 51, 55-62 (2015).
7. Manaenko, A., Chen, H., Kammer, J., Zhang, J. H., & Tang, J. Comparison Evans Blue injection routes: Intravenous versus intraperitoneal, for measurement of blood-brain barrier in a mice hemorrhage model. J Neurosci Methods. 195, 206-210 (2011).
8. Adams, S., & Pacharinsak, C. Mouse anesthesia and analgesia. Curr Protoc Mouse Biol. 5, 51-63 (2015).
9. Zeynalov, E. et al. The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema. Crit Care Med. 36, 2634-2640 (2008).
10. Zeynalov, E., & Dore, S. Low doses of carbon monoxide protect against experimental focal brain ischemia. Neurotox Res. 15, 133-137 (2009).
11. Zeynalov, E., Nemoto, M., Hurn, P. D., Koehler, R. C., & Bhardwaj, A. Neuroprotective effect of selective kappa opioid receptor agonist is gender specific and linked to reduced neuronal nitric oxide. J Cereb Blood Flow Metab. 26, 414-420 (2006).
12. Ma, M. C., Qian, H., Ghassemi, F., Zhao, P., & Xia, Y. Oxygen-sensitive {delta}-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection. J Biol Chem. 280, 16208-16218 (2005).
13. Ahmad, M., Zhang, Y., Liu, H., Rose, M. E., & Graham, S. H. Prolonged opportunity for neuroprotection in experimental stroke with selective blockade of cyclooxygenase-2 activity. Brain Res. 1279, 168-173 (2009).
14. Meisel, C. et al. Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke. 35, 2-6 (2004).
15. Miner, N. A., Koehler, J., & Greenaway, L. Intraperitoneal injection of mice. Appl Microbiol. 17, 250-251 (1969).
16. Conivaptan: YM 087. Drugs in R&D. 5, 94-97 (2004).
17. Murphy, T., Dhar, R., & Diringer, M. Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit. Neurocrit Care. 11, 14-19 (2009).
18. Liu, X., Nakayama, S., Amiry-Moghaddam, M., Ottersen, O. P., & Bhardwaj, A. Arginine-vasopressin V1 but not V2 receptor antagonism modulates infarct volume, brain water content, and aquaporin-4 expression following experimental stroke. Neurocrit Care. 12, 124-131 (2010).
19. Wallace, B. K., Jelks, K. A., & O’Donnell, M. E. Ischemia-induced stimulation of cerebral microvascular endothelial cell Na-K-Cl cotransport involves p38 and JNK MAP kinases. Am J Physiol Cell Physiol. 302, C505-517 (2012).
20. O’Donnell, M. E. et al. Intravenous HOE-642 reduces brain edema and Na uptake in the rat permanent middle cerebral artery occlusion model of stroke: evidence for participation of the blood-brain barrier Na/H exchanger. J Cereb Blood Flow Metab. 33, 225-234 (2013).
21. Walcott, B. P., Kahle, K. T., & Simard, J. M. Novel treatment targets for cerebral edema. Neurotherapeutics. 9, 65-72 (2012).
22. Shen, Z. et al. Inhibition of G protein-coupled receptor 81 (GPR81) protects against ischemic brain injury. CNS Neurosci Ther. 21, 271-279 (2015).